IVD / diagnostics
IVD and diagnostics trials in Australia with a local sponsor
Diagnostics and IVD companies often need Australian evidence for clinical performance, usability, workflow, specimen handling, or broader development and regulatory planning.
The sponsor structure should reflect the assay, intended use, specimen pathway, laboratory model, and data strategy.
Short answer
Clintrail can act as the Australian local sponsor for eligible diagnostics and IVD clinical trials, while the overseas company keeps assay ownership, technical strategy, data strategy, and global development control.
IVD context
IVD studies have their own practical questions.
An IVD or diagnostics study may involve clinical performance, analytical and clinical evidence, specimen handling, laboratory workflow, software, reference methods, data transfer, and intended-use questions.
The TGA's IVD clinical evidence guidance focuses on evidence appropriate to intended use and risk classification, including analytical and clinical characteristics that support the device's intended use.
Sponsor structure
Local sponsorship should be aligned with the specimen and data model.
For overseas diagnostics companies, the Australian sponsor role should not be separated from the realities of how specimens are collected, handled, tested, stored, transferred, or linked with clinical data.
Clintrail can hold the Australian sponsor role while the overseas company retains the IVD development plan, assay strategy, statistical and data strategy, laboratory model, and global evidence plan.
Planning inputs
What to prepare before discussing local sponsorship.
The initial discussion should cover whether the product is an IVD, software as an IVD, companion diagnostic, laboratory assay, point-of-care test, or another diagnostics product, and whether the Australian activity involves a clinical trial using unapproved therapeutic goods.
- Intended use and target population.
- Specimen type, collection workflow, storage, transfer, and testing location.
- Clinical performance endpoints and reference methods.
- Laboratory, site, and investigator responsibilities.
- Data flow, privacy, and records model.
- Current thinking on CTN or CTA pathway if relevant.
Practical matrix
Diagnostics and IVD responsibility split
A practical responsibility matrix helps align sponsor accountability with laboratory and data workflows.
| Area | Clintrail as Australian sponsor | Overseas diagnostics company |
|---|---|---|
| Assay and intended use | Reviews sponsor implications for the Australian study. | Owns the assay, intended use, evidence plan, and technical strategy. |
| Specimens and labs | Confirms sponsor-side visibility of agreed local responsibilities. | Defines specimen handling, lab workflow, reference methods, and data requirements. |
| Evidence and data | Maintains Australian sponsor boundaries and records interfaces. | Controls statistical strategy, data interpretation, and global evidence use. |
Common questions
Questions overseas teams usually ask
Can Clintrail act as sponsor for IVD clinical performance studies?
Clintrail can consider eligible diagnostics and IVD studies where the Australian sponsor role, specimen workflow, laboratory responsibilities, data strategy, safety reporting, and pathway are clear.
Are IVD studies always CTN studies?
No. Whether CTN or CTA is relevant depends on whether the clinical trial involves unapproved therapeutic goods and the specific product, study design, and pathway assessment.
What makes IVD sponsorship different from a drug study?
IVD studies often place more emphasis on intended use, analytical and clinical performance, specimens, laboratories, reference methods, software, usability, and data handling.
Source context
Grounded in Australian clinical trial requirements.
These pages are written for planning clarity. They do not replace legal, tax, regulatory, insurance, ethics, or clinical operations advice for a specific trial.
Related pages
Continue the sponsor-structure research
CTN vs CTA in Australia for overseas sponsors
A practical guide for overseas sponsors comparing Australia's CTN and CTA pathways and understanding where the Australian local sponsor fits.
Australian clinical trial sponsor responsibilities
What overseas sponsors need to understand about the Australian clinical trial sponsor role, sponsor oversight, approvals, safety, records, and responsibility allocation.
Medical device trials in Australia with a local sponsor
How overseas medical device companies can use an Australian local sponsor for Australian clinical trials, including device-specific sponsor considerations.
Run a clinical trial in Australia without setting up a local entity
How overseas companies can avoid forming an Australian subsidiary solely to hold the clinical trial sponsor role.
Next step
Need an Australian local sponsor?
Send through a short description of the clinical trial and your planned Australian activity. We will review it and get back to you soon.